We developed an innovative conjugate of stroke‐homing peptide (SHp) and DNase1 (SHp‐DNase1) to enhance the stability of DNase in the bloodstream while selectively targeting NETs in thromboembolic events. The gene discussed is DNASE1; the disease is Stroke.